Maharashtra Herald

The Global Biosurgery Market to Amount to $15390.1 Million by 2028

 Breaking News
  • No posts were found

The Global Biosurgery Market to Amount to $15390.1 Million by 2028

July 23
16:09 2021
The Global Biosurgery Market to Amount to $15390.1 Million by 2028

Biosurgery Market
As per Triton’s report, the global biosurgery market, which generated $8516.6 million in 2020, is likely to chart 6.21% of CAGR by the year 2028.

As per Triton’s report, the global biosurgery market, which generated $8516.6 million in 2020, is likely to chart 6.21% of CAGR by the year 2028.

A recent study by Triton Market Research titled ‘Global Biosurgery Market,’ covers the Global Analysis and Forecasts by Product (Hemostatic Agents; Bone-Graft Substitutes [Demineralized Bone Matrix; Synthetic Graft Extenders; Cell-Based Matrices; Bone Morphogenetic Proteins]; Surgical Sealing Agents [Synthetic; Natural]; Soft-Tissue Management [Natural Mesh/Patch; Synthetic Mesh/Patch]; Staple Line Reinforcement; Anti-Adhesive Agents); by Application (Cardio and Thoracic Surgery; Orthopedic Surgery; General Surgery; Neuro and Spine Surgery; Other Applications); by Source Type (Synthetic; Natural); and Regional Outlook (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa).

Request Free Sample of the Global Biosurgery Market Report @ https://www.tritonmarketresearch.com/reports/biosurgery-market#request-free-sample  

The report by Triton estimates the global biosurgery market to exhibit a CAGR of 6.21% in the forecasting years from 2021 to 2028. This industry is likely to accumulate a revenue of $15390.1 million by 2028.

Globally, there has been a rise in the average life expectancy, and this has consequently increased the geriatric population. People in this age group are highly prone to several health conditions and age-related comorbidities. This has increased the number of people opting for biosurgery, and is aiding the growth of the market studied. However, there are certain risks related to this procedure, as it may negatively affect the immune response. This is creating is a major hindrance for the growth of the biosurgery market.

The market for biosurgery is segmented into product, application, and source type. Based on product, it is divided into hemostatic agents, bone-graft substitutes, surgical sealing agents, soft-tissue management, staple line reinforcement, and anti-adhesive agents. 

The bone-graft substitutes segment is further divided into demineralized bone matrix, synthetic graft extenders, cell-based matrices, and bone morphogenetic proteins. Whereas, the surgical sealing agents segment is further divided into synthetic and natural. The soft-tissue management segment is sub-segmented into natural mesh/patch and synthetic mesh/patch. 

Based on application, it is categorized into cardio and thoracic surgery, orthopedic surgery, general surgery, neuro and spine surgery, and other applications. And lastly, according to source type, it is classified into synthetic and natural.

North America is presently leading the global biosurgery market, and is expected to maintain its leading position until the end of the forecasted duration. Factors such as the growing aging population and the increasing rate of prevalence of chronic diseases, particularly cancer and cardiovascular disease, along with the rapid technological developments and the growing government investments are increasing the demand for biosurgcal procedures in this region. This is expected to eventually foster the growth of the market in the coming years.

Ethicon Inc (Johnson & Johnson), Baxter International Inc, Zimmer Biomet Holdings Inc, RTI Surgical, Medtronic Plc, Sanofi, Becton, Wright Medical Group NV, CSL Limited, Stryker Corporation, Dickinson and Company, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, and B Braun Melsungen AG are the well-known players in the biosurgery market.

Purchase this Report @  https://www.tritonmarketresearch.com/reports/biosurgery-market#purchase-option 

 

Question & Answer: Biosurgery Market

Question 1: What factor is aiding the growth of the biosurgery market?

Answer: Globally, there has been a rise in the average life expectancy, and this has consequently increased the geriatric population. People in this age group are highly prone to several health conditions and age-related comorbidities. This has increased the number of people opting for biosurgery, and is aiding the growth of the market studied.

Question 2: What factor is creating is a major hindrance for the growth of the biosurgery market?

Answer: There are certain risks related to biosurgery, as it may negatively affect the immune response. This is creating is a major hindrance for the growth of the market.

Question 3: Which region is expected to dominate the global biosurgery market over the forecasting period?

Answer: North America is presently leading the global biosurgery market, and is expected to maintain its leading position until the end of the forecasted duration. Factors such as the growing aging population and the increasing rate of prevalence of chronic diseases, particularly cancer and cardiovascular disease, along with the rapid technological developments and the growing government investments are increasing the demand for biosurgcal procedures in this region. This is expected to eventually foster the growth of the market in the coming years.  

Question 4: Who are the well-known players in the biosurgery market?

Answer: Ethicon Inc (Johnson & Johnson), Baxter International Inc, Zimmer Biomet Holdings Inc, RTI Surgical, Medtronic Plc, Sanofi, Becton, Wright Medical Group NV, CSL Limited, Stryker Corporation, Dickinson and Company, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, and B Braun Melsungen AG are the well-known players in the biosurgery market.

Related Report:

Global Cartilage Repair Market

The global cartilage repair market is deemed to register growth at a CAGR of 15.56% during the estimated phase of 2021-2028, while reaping $2625.6 million in revenue by 2028.

The process of cartilage repair encompasses treating a damaged cartilage via different modalities, such as chondrocyte implantation, chondroplasty, juvenile allograft fragments, and autologous osteochondral allograft, in order to restore the normal functioning of the connective tissue.

The cartilage repair market is expected to progress considerably in the coming years, owing to various factors, such as the growing prevalence of obesity & sedentary lifestyle in people, increase in the elderly populace, and a surge in the cases of arthritis all over the globe. However, the high cost of this procedure and the unclear regulatory scenario are some of the factors that impede the market growth. On a positive note, emerging markets, such as China and India, are anticipated to offer lucrative growth avenues to the industry players in the forecast period.

Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/